Related references
Note: Only part of the references are listed.Synthesis of 3-[(N-carboalkoxy)ethylamino]-indazole-dione derivatives and their biological activities on human liver carbonyl reductase
Solomon Berhe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors
Rita Scarpelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity
Mark Hadden et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
5-Piperazinyl-3-sulfonylindazoles as Potent and Selective 5-Hydroxytryptamine-6 Antagonists
Kevin G. Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy
Marvin J. Meyers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles
Maninder Minu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides
Demetrio Raffa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and-2 Mutant Tumors
Philip Jones et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl) ethylamine derivatives as 5-HT2C receptor agonists
Itsuro Shimada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and biological evaluation of 3,5-diaminoindazoles as cyclin-dependent kinase inhibitors
Jinho Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
GdCl3 catalysed Grieco condensation:: A facile approach for the synthesis of novel pyrimidine and annulated pyrimidine fused indazole derivatives in single pot under mild conditions and their anti-microbial activity
T. Yakaiah et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management
Arthur Gomtsyan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1
Nathaniel I. Martin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery of novel indazole-linked triazoles as antifungal agents
Joon Seok Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Synthesis, docking studies and anti-inflammatory activity of 4,5,6,7-tetrahydro-2H-indazole derivatives
Ornelio Rosati et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells
Qiu Zhao et al.
PANCREAS (2007)
Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors
Krista B. Goodman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Design and synthesis of Rho kinase inhibitors (II)
Masayuki Iwakubo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7-diones as inhibitors of protein kinase B/Akt
Jong Hee Ko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists
I Drizin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Indazole N-oxide derivatives as antiprotozoal agents:: Synthesis, biological evaluation and mechanism of action studies
A Gerpe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism:: Role of the cross-talk between calpain and caspase-3 through calpastatin
F Han et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors
L Bouissane et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents
LJ Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
1-((S)-2-aminopropyl)-1H-indazol-6-ol:: A potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity
JA May et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Pharmacological properties of indazole derivatives:: Recent developments
H Cerecetto et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity
AJ Souers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis
M Bhatia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Identification of 2-(4-benzyloxyphenyl)-N-[1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity
AJ Souers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study
G Daidone et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2004)
A novel cyclo-oxygenase-2 inhibitor modulates catabolic and antiinflammatory mediators in osteoarthritis
P Fernández et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolyipyrazoline derivatives as anti-inflammatory agents
MNA Nasr et al.
ARCHIV DER PHARMAZIE (2003)
Synthesis and antiinflammatory activity of novel indazolones
KAM Abouzid et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
Synthesis and antifungal activity of new N-(1-phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides
D Raffa et al.
FARMACO (2002)
Share Paper
